about
Influenza, including the novel H1N1, in organ transplant patients.Diagnosis, management and outcomes of adults hospitalized with influenza.Antimicrobial drug-induced thrombocytopenia: a review of the literature.Development of BK nephropathy in recipients of simultaneous pancreas-kidney transplantation.The epidemiology and prevention of donor-derived infections.Antiviral therapies for respiratory viral infections in lung transplant patients.Antivirals and resistance: influenza virus.The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation.Norovirus infection in solid organ transplant recipients: a single-center retrospective study.Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative.A retrospective study to describe the epidemiology and outcomes of opportunistic infections after abdominal organ transplantation.Deceased organ donor screening for human immunodeficiency virus, hepatitis B, and hepatitis C viruses: Discordant serology and nucleic acid testing results.Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation.The challenge of urinary tract infections in renal transplant recipients.Uniform definitions for donor-derived infectious disease transmissions in solid organ transplantation.Safety and Efficacy of Foscarnet for the Management of Ganciclovir-Resistant or Refractory Cytomegalovirus Infections: A Single Center Study.Impact of Electronic Health Record-Based, Pharmacist-Driven Valganciclovir Dose Optimization in Solid Organ Transplant Recipients.Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.Influenza in Transplant Recipients: Many Outstanding Questions Despite a Growing Body of Data.Early oseltamivir after hospital admission is associated with shortened hospitalization: A five-year analysis of oseltamivir timing and clinical outcomesAppropriateness of Beta-Lactam Allergy Record Updates After an Allergy Service ConsultScreening recipients of increased risk donor organs: A multicenter retrospective studyParainfluenza Virus in Hospitalized Adults: A 7-Year Retrospective StudyAnti-influenza therapy: the emerging challenge of resistanceDifficult cases in immunocompromised patientsDonor derived transmission events in the us: a case-based discussionEditorial [Hot topic: Infectious Diseases and Hematology: At the Crossroad of Contemporary Therapy (Guest Editors: Hau C. Kwaan and Michael G. Ison)]Emerging Infections: Adenovirus Infections in Transplant RecipientsInfluenza in Hospitalized Adults: Gaining Insight into a Significant ProblemInfluenza in pediatric solid-organ transplant recipientsRespiratory infections and antimicrobial resistance – new challengesRespiratory infections in the immunocompromised hostRespiratory viral infections in transplant recipientsUtilization of deceased organ donors based on HIV, hepatitis B virus, and hepatitis C virus screening test resultsSafety and efficacy of methenamine hippurate for the prevention of recurrent urinary tract infections in adult renal transplant recipients: A single center, retrospective studyImpact of the OPTN transmissible diseases policy and US PHS increased risk donor guidelines on living donor candidatesPre- and post-transplant bacterial infections in liver transplant recipientsCase 20-2019: A 52-Year-Old Woman with Fever and Rash after Heart TransplantationEpidemiology and outcomes of hospitalized adults with respiratory syncytial virus: A 6-year retrospective studyA Unique Clade of SARS-CoV-2 Viruses is Associated with Lower Viral Loads in Patient Upper Airways
P50
Q30390777-8BC8E961-7FB2-4219-8000-D97EFD9CB7E9Q30412653-01663326-56C7-4C82-8A13-E9AD07B263E9Q33403911-7B2E361B-0ED1-4B36-91C0-7B83CE7A6D07Q37421209-22A3EC9D-855B-4FDC-A5CB-4B8AE9CF5813Q37540757-F713F447-C434-49E4-BEA1-F1340918C5F1Q37981967-7411A3E8-ECAA-4511-8E5B-A7484EF9C1BAQ37996227-67DF3A66-379B-470F-B014-3FD2C08E90F1Q38757351-778E0B7D-392D-4F06-BFA8-B0DD3F9EFDEFQ39325196-D41F0874-7AAB-4AFA-B723-B4CD0D8E0620Q39962070-DD853E82-7A85-412C-8904-7EA24553DA8CQ40302250-8723D6A1-804C-460B-86CC-91F5D15801F2Q45324209-2A79E6E9-8B24-42F6-BAC8-E6EB8C82F286Q45385020-4F234D0A-7632-4C00-8666-D32D74C787E4Q48356175-D305EDFA-98BD-4E2D-BCEE-90C82D5681CBQ48644770-F301E28E-D2AC-445B-8C32-902657774CC2Q49586205-11E291D7-7342-4965-868A-00359990B101Q49843694-BE6F983F-39AD-429B-A6A4-4A8CB50CDB0BQ52728260-A86336FA-EFAB-40AD-94AB-E6CCEB962891Q54238467-55B31CD8-22FD-4490-B8E1-41C90015CC16Q57288180-4552176C-9FB1-414D-B876-F96EF092F989Q58066865-7B64F9B7-DAEE-49FF-9C99-758487D6E618Q58066866-8784EDFB-4022-4C09-8FB0-0FC8DD788D01Q58066867-D0F983B5-E54C-4AFC-A84C-34957D947C1BQ58066873-A5845AD6-AB7A-4423-A4BF-374AC09BDA32Q58066877-D99A0C45-92A5-4CEC-AA5D-DBB4563E4561Q58066878-44A26B52-8B41-4D0F-A17B-DECD73BE3914Q58066879-ADBC71C8-26EE-4A9E-907F-7FD7983BC112Q58066880-1F7A6C63-E287-42B0-B5DB-33870F82F0C5Q58066883-D758ABAB-A626-42C6-8FF7-54D9A49315E1Q58066884-419BD404-8FEC-4DAB-BCC3-9DD5E2F3EF19Q58066889-13D544B7-67CC-46D6-9AD0-F4E105F4A87AQ58066892-C0CD92E9-5E3F-4B2A-AD4A-12E131CD4451Q58066893-6EDF0BDC-D599-469B-81C6-6CC0BB0312BCQ90123808-56EF1ACA-B176-4ABC-89BB-0BB2BF4800F9Q91676634-7296722F-DCB0-46A3-B443-E16991955104Q92141623-8CF45880-6EF4-42FA-95D5-C5C298570E9DQ92248097-B996FE77-81A1-46D2-BD8B-4E9614537A3FQ93047287-C998125B-A70F-4534-93D5-AEB64775903FQ93049690-C4857796-F8C0-4433-9983-82A1EA584873Q96223909-1CE79991-8C21-4EE0-89EC-FFBC78B7EE9A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael G Ison
@ast
Michael G Ison
@en
Michael G Ison
@es
Michael G Ison
@nl
type
label
Michael G Ison
@ast
Michael G Ison
@en
Michael G Ison
@es
Michael G Ison
@nl
prefLabel
Michael G Ison
@ast
Michael G Ison
@en
Michael G Ison
@es
Michael G Ison
@nl
P106
P2038
Michael_Ison
P31
P496
0000-0003-3347-9671